OKYO Pharma (OKYO) Assets (2021 - 2026)

OKYO Pharma (OKYO) has reported Assets for 6 consecutive years, with $21.0 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Assets rose 470.42% year-over-year to $21.0 million in Q1 2026; TTM through Mar 2026 was $21.0 million, a 470.42% increase from a year earlier, with the FY2026 full-year figure at $21.0 million, up 470.42% from the prior year.
• Assets was $21.0 million for Q1 2026 at OKYO Pharma, up from $4.6 million in the prior quarter.
• Over five years, Assets peaked at $21.0 million in Q1 2026 and troughed at $1.5 million in Q1 2024.
• A 5-year average of $5.7 million and a median of $4.0 million in 2022 frame the typical range for Assets.
• Across the five-year window, Assets plunged 70.38% in 2024 and soared 470.42% in 2026, its largest moves.
• Over 5 years, Assets stood at $4.3 million in 2022, then slumped by 44.72% to $2.4 million in 2023, then increased by 19.0% to $2.8 million in 2024, then soared by 64.16% to $4.6 million in 2025, then jumped by 351.7% to $21.0 million in 2026.
• The last three Assets figures came in at $21.0 million (Q1 2026), $4.6 million (Q3 2025), and $3.7 million (Q1 2025), per Business Quant data.